This is because ANXA2 has been reported to function as a co‐receptor for tissue plasminogen activator (tPA) at the cell surface of endothelial and cancer cells,20, 32, 33 and the current study suggests the co‐localization, dependence and interaction between ANXA2 and EpCAM at the cell surface. Here, EPCAM is linked to cancer.